Results 281 to 290 of about 29,806 (309)

Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond

Chemical Reviews, 2021
Ashley N Matthew, Florian Leidner, Gordon J Lockbaum   +2 more
exaly  

Direct acting antivirals

Reactions Weekly, 2019
openaire   +1 more source

Direct-acting antiviral agents

Reactions Weekly, 2019
openaire   +1 more source

Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: A systematic literature review and meta-analysis

EClinicalMedicine, 2020
Rita E Morassut, Dena Zeraatkar, Roger Chou   +2 more
exaly  

Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes

Nutrition, Metabolism and Cardiovascular Diseases, 2021
Ferdinando Carlo Sasso, Pia Clara Pafundi, Alfredo Caturano   +2 more
exaly  

In the Era of Direct-Acting Antivirals, Liver Transplant Delisting Due to Clinical Improvement for Hepatitis C Remains Infrequent

Clinical Gastroenterology and Hepatology, 2021
Therese Bittermann, K Rajender Reddy
exaly  

Direct‐acting antivirals and recurrence of hepatocellular carcinoma

Liver Transplantation, 2017
Jorge A, Marrero, Amit G, Singal
openaire   +2 more sources

Treatment of chronic hepatitis C-associated cryoglobulinemia vasculitis at the era of direct-acting antivirals

Therapeutic Advances in Gastroenterology, 2020
Cloé Comarmond, Patrice Cacoub, David Saadoun   +2 more
exaly  

The oncologic burden of hepatitis C virus infection: A clinical perspective

Ca-A Cancer Journal for Clinicians, 2017
Harrys A Torres, Nassim Hammoudi, V Olivier Mallet   +2 more
exaly  

Direct-acting antiviral therapy in sub-Saharan Africa

The Lancet Gastroenterology & Hepatology, 2019
C Wendy, Spearman, Mark W, Sonderup
openaire   +2 more sources